Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Eledon Pharmaceuticals Inc (ELDN)

120 + Investors. Track Smart Money conviction in ELDN. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +27
Streak
2Q ▲
Buyers last Q
67%

Smart Money Signals — ELDN

Based on 121 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added ELDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
121 hedge funds hold ELDN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +48% more funds vs a year ago

fund count last 6Q
+39 new funds entered over the past year (+48% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 67% buying

77 buying38 selling
Last quarter: 77 funds were net buyers (43 opened a brand new position + 34 added to an existing one). Only 38 were sellers (22 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+11 vs last Q)

new funds entering per quarter
Funds opening a new ELDN position: 28 → 21 → 32 → 43. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 55% entered in last year

■ 21% conviction (2yr+) ■ 25% medium ■ 55% new
Only 25 funds (21%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Price up while funds trimmed (+93% value, -3% shares)

Value
+93%
Shares
-3%
Last quarter: total value of institutional ELDN holdings rose +93% even though funds reduced share count by 3%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
🚀

Acceleration phase — new buyers rushing in

18 → 28 → 21 → 32 → 43 new funds/Q
New funds entering each quarter: 28 → 21 → 32 → 43. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🌱

Early stage — 65% of holders entered in last year

■ 23% veterans ■ 12% 1-2yr ■ 65% new
Of 121 current holders: 79 (65%) entered in the past year, only 28 (23%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋

Smaller funds dominant — 16% AUM from top-100

16% from top-100 AUM funds
28 of 121 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.9
out of 10
Moderate Exit Risk
Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ELDN

In 2026 Q1, 77 hedge funds were net buyers of ELDN (43 opened a new position, 34 added to an existing one), while 38 reduced or exited (22 trimmed, 16 sold completely) — a 67% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +27 funds (more new holders than closures). Total institutional holders: 121.

Hedge Fund Ownership: ELDN

How many hedge funds hold ELDN — quarterly history vs. share price
Quarterly hedge fund ownership of ELDN vs. share price

Market Analysis: ELDN

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ELDN

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Eledon Pharmaceuticals Inc (ELDN) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ELDN has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
ELDN
+15.9%
XLV
+4.9%

ELDN outperformed XLV by +11.0% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
ELDN
-6.1%
XLV
+6.0%

Since the filing became public, ELDN outperformed XLV by -12.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

14 top-rated funds 1 high-conviction
Consensus
5.1
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: ELDN
120 + Investors

Track Smart Money conviction in ELDN. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 120 94 27.66%
13F Shares 43M 44M -3.46%
Total Value $129M $67M 93.19%
New Positions 42 32 +10
Increased Positions 33 32 +1
Closed Positions 16 21 -5
Reduced Positions 22 16 +6
Total Calls 2 1 100.0%
Total Puts 0 2 -100.0%
PUT/CALL Ratio 0.0 2.0 Bullish

Statistics: ELDN

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

120 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ELDN. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ELDN holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 CM Management, LLC 1.67% 650,000 $2.0M
2 Defilade Capital Management, L.P. 1.54% 3,564,127 $11.0M
3 22nw, LP 1.34% 636,364 $2.0M
4 Blue Owl Capital Holdings LP 1.18% 1,419,912 $4.4M
5 Catalio Capital Management, LP 1.06% 1,639,816 $5.1M
6 Sphera Funds Management LTD. 0.87% 1,772,131 $5.5M
7 Sanofi 0.75% 814,980 $2.5M
8 Bvf Inc/Il 0.62% 6,293,282 $19.4M
9 AWM Investment Company, Inc. 0.38% 1,100,000 $3.4M
10 Kingdon Capital Management, L.L.C. 0.35% 1,039,275 $3.2M
11 Daytona Street Capital LLC 0.20% 81,166 $254K
12 ADAR1 Capital Management, LLC 0.18% 974,421 $3.0M
13 Zimmer Partners, LP 0.14% 1,875,000 $5.8M
14 Stonepine Capital Management, LLC 0.04% 35,000 $108K
15 Mitchell & Pahl Private Wealth, LLC 0.04% 30,000 $92K
16 PW Nova Financial Services LLC 0.04% 58,041 $94K
17 Split Rock Private Trading & Wealth Management, LLC 0.02% 10,000 $31K
18 Jefferies Financial Group Inc. 0.02% 1,094,456 $3.4M
19 BIT Capital GmbH 0.02% 134,000 $413K
20 Kera Capital Partners, Inc. 0.02% 39,908 $123K
21 Ensign Peak Advisors, Inc 0.01% 2,464,919 $7.6M
22 Howard Financial Services, LTD. 0.01% 30,000 $92K
23 Forum Private Client Group LLC 0.01% 10,000 $31K
24 Marco Investment Management LLC 0.01% 30,344 $93K
25 Baker Ellis Asset Management LLC 0.01% 19,000 $59K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Eledon Pharmaceuticals Inc (ELDN)

What does the Smart Money Trend signal show for ELDN?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added ELDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ELDN?

More buyers than sellers — 67% buying: Last quarter: 77 funds were net buyers (43 opened a brand new position + 34 added to an existing one). Only 38 were sellers (22 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ELDN holders?

Smaller funds dominant — 16% AUM from top-100: 28 of 121 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ELDN?

Mostly new holders — 55% entered in last year: Only 25 funds (21%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Eledon Pharmaceuticals Inc (ELDN) following the 2026 Q1 hedge fund 13F filings?

As of today, ELDN has moved -6.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -12.1%. Since the quarter end (March 31, 2026), ELDN has gained +15.9% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →